TrialSpark is a technology company focused on accelerating the pace of clinical trials to bridge the gap between medical research and patients who need treatment.
TrialSpark does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for TrialSpark will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/6/2021 | Series C | $1.04B | $XXX.XX | $XXX.XX |
| 10/15/2018 | Series B | $377.41MM | $XXX.XX | $XXX.XX |
| 9/28/2017 | Series A | $65.83MM | $XXX.XX | $XXX.XX |
| 6/30/2016 | Series Seed | $9MM | $XXX.XX | $XXX.XX |
